Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Evol Science

Evol Science
2014 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Owner and operator of a biotechnology company intended to identify and therapeutically exploit mechanisms of cancer cell resistance. The company's proteomics platform, metadata analysis and predictive analytics develops new targeted therapies to treat various diseases such as pancreatic cancer, acquired resistance metastatic melanoma and others, enabling doctors to make the deadly cancers survivable.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Application Software
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
  • 3711 Market Street
  • Suite 800
  • Philadelphia, PA 19104
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Evol Science’s full profile, request a free trial.

Evol Science Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Evol Science Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Science Center Accelerator/Incubator 000 0000 000000 0

Evol Science Executive Team (4)

Name Title Board
Seat
Contact
Info
Joseph Driscoll Co-Founder & Chief Executive Officer
Andy Andrews Ph.D Co-Founder, Consultant & Chief Scientific Advisor
Vikram Bhattacharjee Co-Founder & Primary Scientist
Tim Yen Ph.D Interim CSO